Evidence map›Paper›PMID 19756449›Full record

ArticleJournal of molecular medicine (Berlin, Germany)2009

Sgk1 activates MDM2-dependent p53 degradation and affects cell proliferation, survival, and differentiation.

Rosario Amato, Lucia D'Antona, Giovanni Porciatti, Valter Agosti, Miranda Menniti, Cinzia Rinaldo, Nicola Costa, Emanuele Bellacchio, Stefano Mattarocci, Giorgio Fuiano and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of molecular medicine (Berlin, Germany), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 102 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Genome-wide integration of microRNA and transcriptomic profiles of differentiating human alveolar epithelial cells.American journal of physiology. Lung cellular and molecular physiology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 2 countries.

Rosario AmatoDepartment of Experimental and clinical Medicine G. Salvatore, Faculty of Medicine, University Magna Graecia at Catanzaro, Catanzaro, Italy.
Lucia D'Antona
Giovanni Porciatti
Valter Agosti
Miranda Menniti
Cinzia Rinaldo
Nicola Costa
Emanuele Bellacchio
Stefano Mattarocci
Giorgio Fuiano
Silvia Soddu
Marco G Paggi
Florian Lang
Nicola Perrotti
Magna Graecia University · ITUniversity of Tübingen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Serum and glucocorticoid regulated kinase 1 (Sgk1) is a serine-threonine kinase that is activated by serum, steroids, insulin, vasopressin, and interleukin 2 at the transcriptional and post-translational levels. Sgk1 is also important in transduction of growth factors and steroid-dependent survival signals and may have a role in the development of resistance to cancer chemotherapy. In the present paper, we demonstrate that Sgk1 activates MDM2-dependent p53 ubiquitylation. The results were obtained in RKO cells and other cell lines by Sgk1-specific RNA silencing and were corroborated in an original mouse model as well as in transiently and in stably transfected HeLa cells expressing wild-type or dominant negative Sgk1 mutant. Sgk1 contributes to cell survival, cell-cycle progression, and epithelial de-differentiation. We also show that the effects of Sgk1 on the clonogenic potential of different cancer cells depend on the expression of wild-type p53. Since transcription of Sgk1 is activated by p53, we propose a finely tuned feedback model where Sgk1 down-regulates the expression of p53 by enhancing its mono- and polyubiquitylation.

Indexed as

Cell DifferentiationCell ProliferationCell SurvivalGene Expression Regulation, NeoplasticImmediate-Early ProteinsProtein Serine-Threonine KinasesProto-Oncogene Proteins c-mdm2Tumor Suppressor Protein p53AnimalsCell DeathCell LineHeLa CellsHumansMaleMiceMice, Inbred BALB CImmediate-Early ProteinsMDM2 protein, humanProtein Serine-Threonine KinasesProto-Oncogene Proteins c-mdm2Serum-Glucocorticoid Regulated KinasesTumor Suppressor Protein p53

Identifiers

PMID19756449
OpenAlexW2121058265

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.